Arena Pharmaceuticals Names Business Head

San Diego-based Arena Pharmaceuticals announced this morning that it has named Vincent Aurentz as its new Executive Vice President and Chief Business Officer. The developer of small molecule drugs, with potential treatments for ulcerative colitis, Crohn's disease, and pulmonary arterial hypertension, said Aurentz joins from Epirus Biopharmaceuticals, where he was Chief Business Officer. He also has served at HemoShear Therapeutics, Merck KGaA, Quintiles, and Andersen Consulting (now Accenture).